Canada's New Process For Approval Of Biosimilar Drugs
Canada has joined Europe, Japan and several other jurisdictions in providing an administrative pathway for approval of "biosimilar" or "follow-on biologic" drugs. These drugs, known in Canada as "Subsequent Entry Biologics"...To view the full article, register now.
Already a subscriber? Click here to view full article